Health Trials

Relapsed B-cell NHL

1

Review clinical trials related to Relapsed B-cell NHL. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL

To learn if giving mosunetuzumab in combination with polatuzumab vedotin, tafasitamab, and lenalidomide can help to control relapsed/refractory FL and DLBCL.

Participants needed: 36
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: M.D. Anderson Cancer CenterUpdated: May 20, 2026Locations: 1
Eligibility criteria

A diagnosis of relapsed CD20+ Follicular Lymphoma grade 1-3a [+15]

Known hypersensitivity to any study drug [+33]

Read more